[1]尹鹏林,姜萌萌,朱亚萍,等.中药促治疗性血管新生研究进展[J].中国中医药信息杂志,2021,28(12):134-139.[doi:10.19879/j.cnki.1005-5304.202104503]
 YIN Penglin,JIANG Mengmeng,ZHU Yaping,et al.Research Progress in Chinese Materia Medica Promoting Therapeutic Angiogenesis[J].zhongguo zhongyiyao xinxi zazhi,2021,28(12):134-139.[doi:10.19879/j.cnki.1005-5304.202104503]
点击复制

中药促治疗性血管新生研究进展

参考文献/References:

[1] VIALLARD C, LARRIV E B. Tumor angiogenesis and vascular normalizationalternative therapeutic targets[J]. Angiogenesis, 2017,20(4)409-426.

[2] ELSHABRAWY H A, CHEN Z, VOLIN M V, et al. The pathogenic role of angiogenesis in rheumatoid arthritis[J]. Angiogenesis,2015, 18(4)433-448.

[3] MANUEL G E, JOHNSON T, LIU D. Therapeutic angiogenesis of exosomes for ischemic stroke[J]. Int J Physiol Pathophysiol Pharmacol,2017,9(6)188-191.

[4] BU L, DAI O, ZHOU F, et al. Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis[J]. Biomedicine & Pharmacotherapy,2020,132110855.

[5] CARMELIET P, JAIN R K. Molecular mechanisms and clinical applications of angiogenesis[J]. Nature,2011,473(7347)298-307.

[6] ZHAO L, JOHNSON T, LIU D. Therapeutic angiogenesis of adipose- derived stem cells for ischemic diseases[J]. Stem Cell Research & Therapy,2017,8(1)125.

[7] JOHNSON T, ZHAO L, MANUEL G, et al. Approaches to therapeutic angiogenesis for ischemic heart disease[J]. Journal of Molecular Medicine (Berlin, Germany),2019,97(2)141-151.

[8] HATAKEYAMA M, NINOMIYA I, KANAZAWA M. Angiogenesis and neuronal remodeling after ischemic stroke[J]. Neural Regeneration Research, 2020,15(1)16-19.

[9] D?/span>BROWSKI J, CZAJKA A, ZIELI?/span>SKA-TUREK J, et al. Brain functional reserve in the context of neuroplasticity after stroke[J]. Neural Plasticity,2019,20199708905.

[10] MINISTRO A, DE OLIVEIRA P, NUNES R J, et al. Assessing therapeutic angiogenesis in a murine model of hindlimb ischemia[J]. Journal of Visualized Experiments,2019,148e59582.

[11] DAI X, YAN X, ZENG J, et al. Elevating CXCR7 improves angiogenic function of EPCs via Akt/GSK-3β/Fyn-mediated Nrf2 activation in diabetic limb ischemia[J]. Circulation Research,2017,120(5)e7-e23.

[12] LAI P K, CHAN J Y, KWOK H F, et al. Induction of angiogenesis in zebrafish embryos and proliferation of endothelial cells by an active fraction isolated from the root of Astragalus membranaceus using bioassay-guided fractionation[J]. Journal of Traditional and Complementary Medicine,2014,4(4)239-245.

[13] CHENG C Y, HO T Y, HSIANG C Y, et al. Angelica sinensis exerts angiogenic and anti-apoptotic effects against cerebral ischemia- reperfusion injury by activating p38MAPK/HIF-1/VEGF-A signaling in rats[J]. The American Journal of Chinese Medicine,2017,45(8)1683-1708.

[14] WANG D, JIE Q, LIU B, et al. Saponin extract from Panax notoginseng promotes angiogenesis through AMPK- and eNOS- dependent pathways in HUVECs[J]. Molecular Medicine Reports, 2017,16(4)5211-5218.

[15] YANG B R, CHEUNG K K, ZHOU X, et al. Amelioration of acute myocardial infarction by saponins from flower buds of Panax notoginseng via pro-angiogenesis and anti-apoptosis[J]. Journal of Ethnopharmacology,2016,18150-58.

[16] ZHOU X, SIU W S, FUNG C H, et al. Pro-angiogenic effects of Carthami Flos whole extract in human microvascular endothelial cells in vitro and in zebrafish in vivo[J]. Phytomedicine,2014, 21(11)1256-1263.

[17] CHUNG B H, CHO Y L, KIM J D, et al. Promotion of direct angiogenesis in vitro and in vivo by Puerariae flos extract via activation of MEK/ERK-, PI3K/Akt/eNOS-, and Src/FAK-dependent pathways[J]. Phytotherapy Research,2010,24(6)934-940.

[18] HUANG S T, CHANG C C, PANG J S, et al. Drynaria fortunei promoted angiogenesis associated with modified MMP-2/TIMP-2 balance and activation of VEGF ligand/receptors expression[J]. Frontiers in Pharmacology,2018,9979.

[19] 白晓君,任建勋,张卫萍.淫羊藿总黄酮对大鼠急性心肌梗死后缺血心肌血管新生作用的影响[J].中国实验方剂学杂志,2021,27(12)40- 47.

[20] CHENG S, ZHANG X, FENG Q, et al. Astragaloside exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway[J]. Life Sciences, 2019,22782-93.

[21] 杨雷,刘萍,刘暖,.黄芪甲苷对EPCsSDF-1α/CXCR4的调控作用[J].中国病理生理杂志,2019,35(9)1587-1593.

[22] CAI H A, HUANG L, ZHENG L J, et al. Ginsenoside (Rg-1) promoted the wound closure of diabetic foot ulcer through iNOS elevation via miR-23a/IRF-1 axis[J]. Life Sciences,2019,233116525.

[23] CHEN J, ZHANG X, LIU X, et al. Ginsenoside Rg1 promotes cerebral angiogenesis via the PI3K/Akt/mTOR signaling pathway in ischemic mice[J]. European Journal of Pharmacology,2019,856172418.

[24] TANG Y, VATER C, JACOBI A, et al. Salidroside exerts angiogenic and cytoprotective effects on human bone marrow-derived endothelial progenitor cells via Akt/mTOR/p70S6K and MAPK signalling pathways[J]. British Journal of Pharmacology,2014, 171(9)2440-2456.

[25] CHEN P, LIU J, RUAN H, et al. Protective effects of Salidroside on cardiac function in mice with myocardial infarction[J]. Scientific Reports,2019,9(1)18127.

[26] YANG B R, HONG S J, LEE S M, et al. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo[J]. Chinese Journal of Integrative Medicine, 2016,22(6)420-429.

[27] LI Y J, DUAN C L, LIU J X. Salvianolic acid A promotes the acceleration of neovascularization in the ischemic rat myocardium and the functions of endothelial progenitor cells[J]. Journal of Ethnopharmacology,2014,151(1)218-227.

[28] 吕娟,赵红梅,孙桂芳,.丹酚酸B诱导血管新生和缓解氧化应激对局灶性脑缺血再灌注大鼠脑组织损伤的保护作用[J].中国免疫学杂志,2019,35(10)1174-1178.

[29] 刘暖,杨雷,毛秉豫.丹参酚酸B调控PKD1-HIF-1α-VEGF通路促心肌梗死大鼠血管新生的作用[J].中国药理学通报,2020,36(7)984-990.

[30] ZHENG Y, WU Z, YI F, et al. By activating Akt/eNOS bilobalide b inhibits autophagy and promotes angiogenesis following focal cerebral ischemia reperfusion[J]. Cellular Physiology and Biochemistry,2018,47(2)604-616.

[31] CHEN M, ZOU W, CHEN M, et al. Ginkgolide K promotes angiogenesis in a middle cerebral artery occlusion mouse model via activating JAK2/STAT3 pathway[J]. European Journal of Pharmacology,2018, 833221-229.

[32] WEI G, YIN Y, DUAN J, et al. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/ VEGF-A/SDF-1α cascade[J]. Biomedicine & Pharmacotherapy,2017, 88409-420.

[33] CHEN T, CHEN N, PANG N, et al. Hydroxysafflor yellow A promotes angiogenesis via the angiopoietin 1/Tie-2 signaling pathway[J]. Journal of Vascular Research,2016,53(5/6)245-254.

[34] LIU Y, TANG Q, SHAO S, et al. Lyophilized powder of catalpol and puerarin protected cerebral vessels from ischemia by its anti-apoptosis on endothelial cells[J]. International Journal of Biological Sciences,2017,13(3)327-338.

[35] SONG N, ZHAO Z, MA X, et al. Naringin promotes fracture healing through stimulation of angiogenesis by regulating the VEGF/ VEGFR-2 signaling pathway in osteoporotic rats[J]. Chemico- Biological Interactions,2017,26111-17.

[36] ZHENG X W, SHAN C S, XU Q Q, et al. Buyang Huanwu decoction targets SIRT1/VEGF pathway to promote angiogenesis after cerebral ischemia/reperfusion injury[J]. Frontiers in Neuroscience,2018, 12911.

[37] CUI H J, YANG A L, ZHOU H J, et al. Buyang Huanwu decoction promotes angiogenesis via vascular endothelial growth factor receptor-2 activation through the PI3K/Akt pathway in a mouse model of intracerebral hemorrhage[J]. BMC Complementary and Alternative Medicine,2015,1591.

[38] SHEN J, ZHU Y, YU H, et al. Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia[J]. Journal of Zhejiang University Science B,2014,15(3)272-280.

[39] ZHU J Z, BAO X Y, ZHENG Q, et al. Buyang Huanwu Decoction exerts cardioprotective effects through targeting angiogenesis via caveolin-1/VEGF signaling pathway in mice with acute myocardial infarction[J]. Oxidative Medicine and Cellular Longevity,2019, 20194275984.

[40] WANG H, QIU L, MA Y, et al. Naoxintong inhibits myocardial infarction injury by VEGF/eNOS signaling-mediated neovascularization[J]. Journal of Ethnopharmacology,2017,20913-23.

[41] CHEN L, ZHANG L, FANG Z, et al. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism[J]. Journal of Ethnopharmacology, 2018,227121-130.

[42] SHI W L, LU P F, GAO D, et al. Effect of Xuefu Zhuyu Capsule (血府逐瘀胶囊) on angiogenesis in hindlimb ischemic rats[J]. Chinese Journal of Integrative Medicine,2020,26(1)39-45.

[43] SONG J, CHEN W Y, WU L Y, et al. A microarray analysis of angiogenesis modulation effect of Xuefu Zhuyu Decoction (血府逐瘀汤) on endothelial cells[J]. Chinese Journal of Integrative Medicine,2012,18(7)502-506.

[44] LIN F, CHEN B L, WANG Y Z, et al. In vitro angiogenesis effect of Xuefu Zhuyu Decoction (血府逐瘀汤) and vascular endothelial growth factora comparison study[J]. Chinese Journal of Integrative Medicine,2018,24(8)606-612.

[45] ZHANG L, WANG Y, YU L, et al. QI-SHEN-YI-QI accelerates angiogenesis after myocardial infarction in rats[J]. International Journal of Cardiology,2010,143(1)105-109.

[46] DAI G H, LIU N, ZHU J W, et al. Qi-Shen-Yi-Qi Dripping pills promote angiogenesis of ischemic cardiac microvascular endothelial cells by regulating microRNA-223-3p expression[J]. Evidence-based Complementary and Alternative Medicine,2016, 20165057328.

[47] HE G X, XIE J, JIANG H, et al. Effects of Qishen Yiqi Dripping Pills (芪参益气滴丸) in reducing myocardial injury and preserving microvascular function in patients undergoing elective percutaneous coronary interventiona pilot randomized study[J]. Chinese Journal of Integrative Medicine,2018,24(3)193-199.

[48] HU G, YANG P, ZENG Y, et al. Danggui Buxue decoction promotes angiogenesis by up-regulation of VEGFR(1/2) expressions and down-regulation of sVEGFR(1/2) expression in myocardial infarction rat[J]. Journal of the Chinese Medical Association, 2018,81(1)37-46.

[49] CUI M D, PAN Z H, PAN L Q. Danggui Buxue extract-loaded liposomes in thermosensitive gel enhance in vivo dermal wound healing via activation of the VEGF/PI3K/Akt and TGF-β/Smads signaling pathway[J]. Evidence-based Complementary and Alternative Medicine, 2017,20178407249.

相似文献/References:

[1]廖利平,林晓生,易炳学,等.关于中药方剂编码的研究[J].中国中医药信息杂志,2011,18(1):34.[doi:10.3969/j.issn.1005-5304.2011.01.013]
 LIAO Li-ping,LIN Xiao-sheng,YI Bing-xue,et al.Study on Chinese Herbal Medicine Prescription Coding[J].zhongguo zhongyiyao xinxi zazhi,2011,18(12):34.[doi:10.3969/j.issn.1005-5304.2011.01.013]
[2]董宇,王阶,杨庆,等.CYP450酶与中药代谢相互作用关系研究概况[J].中国中医药信息杂志,2011,18(1):100.[doi:10.3969/j.issn.1005-5304.2011.01.052]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(12):100.[doi:10.3969/j.issn.1005-5304.2011.01.052]
[3]康旭亮,吕茂平,李洪梅.抗流行性感冒的中药发明专利状况分析[J].中国中医药信息杂志,2012,19(3):1.[doi:10.3969/j.issn.1005-5304.2012.03.001]
 [J].zhongguo zhongyiyao xinxi zazhi,2012,19(12):1.[doi:10.3969/j.issn.1005-5304.2012.03.001]
[4]王仲易,李敏.针药结合治疗下元虚寒型小儿遗尿症疗效观察[J].中国中医药信息杂志,2014,21(3):92.[doi:10.3969/j.issn.1005-5304.2014.03.029]
 [J].zhongguo zhongyiyao xinxi zazhi,2014,21(12):92.[doi:10.3969/j.issn.1005-5304.2014.03.029]
[5]高欣,康立源,高秀梅.脑缺血后神经细胞凋亡通路及中药干预[J].中国中医药信息杂志,2007,14(7):96.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(12):96.
[6]张萍.中西药配伍的药理分析[J].中国中医药信息杂志,2007,14(7):104.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(12):104.
[7]刘真,魏运湘,于慧卿,等.四妙勇安汤对缺氧人脐静脉内皮细胞的影响[J].中国中医药信息杂志,2010,17(5):31.
 LIU Zhen,WEI Yun-xiang,YU Hui-qing,et al.Effect of Simiaoyongantang on Human Umbilical Vein Endothelial Cells Injured by Hypoxia[J].zhongguo zhongyiyao xinxi zazhi,2010,17(12):31.
[8]田 茸,陈 丽,杨延婷,等.单味中药抗癫痫效应的规律分析及其Logistic回归模型[J].中国中医药信息杂志,2010,17(11):97.
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(12):97.
[9]刘 盈,黄璐琦,边宝林,等.中药新药研发医、研、产合作创新网络构建探讨[J].中国中医药信息杂志,2010,17(12):7.[doi:10.3969/j.issn.1005-5304.2010.12.004]
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(12):7.[doi:10.3969/j.issn.1005-5304.2010.12.004]
[10]刘起华,文谨,王菲,等.中药穴位给药应用研究概述[J].中国中医药信息杂志,2010,17(2):104.
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(12):104.
[11]陈清华,指导:袁肇凯.中医药与血管新生研究进展[J].中国中医药信息杂志,2007,14(8):89.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(12):89.
[12]陈裴裴,周昕,谢瑞芳.基于心肌缺血的中药促血管新生机制研究进展[J].中国中医药信息杂志,2014,21(5):133.[doi:10.3969/j.issn.1005-5304.2014.05.048]
 [J].zhongguo zhongyiyao xinxi zazhi,2014,21(12):133.[doi:10.3969/j.issn.1005-5304.2014.05.048]

备注/Memo

基金项目:天津市自然科学基金重点项目(19JCZDJC37100)

更新日期/Last Update:

2021-11-13